<SEC-DOCUMENT>0001005286-24-000071.txt : 20240522
<SEC-HEADER>0001005286-24-000071.hdr.sgml : 20240522
<ACCEPTANCE-DATETIME>20240522163008
ACCESSION NUMBER:		0001005286-24-000071
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240519
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240522
DATE AS OF CHANGE:		20240522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIFECORE BIOMEDICAL, INC. \DE\
		CENTRAL INDEX KEY:			0001005286
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				943025618
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0528

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27446
		FILM NUMBER:		24973721

	BUSINESS ADDRESS:	
		STREET 1:		3515 LYMAN BOULEVARD
		CITY:			CHASKA
		STATE:			MN
		ZIP:			55318
		BUSINESS PHONE:		9523684300

	MAIL ADDRESS:	
		STREET 1:		3515 LYMAN BOULEVARD
		CITY:			CHASKA
		STATE:			MN
		ZIP:			55318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LANDEC CORP \CA\
		DATE OF NAME CHANGE:	19951222
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lndc-20240519.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:cfacfc41-a0b5-4de1-8079-b8c458288541,g:a394aa73-034b-4302-b53c-b8c0aae0a0c1,d:c1b6338d76814ba78e54bc0bef9e66a9-->
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lndc-20240519</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-21">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001005286</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lndc-20240519.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001005286</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-19</xbrli:startDate><xbrli:endDate>2024-05-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic1b6338d76814ba78e54bc0bef9e66a9_1"></div><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="padding-left:9pt;padding-right:9pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="padding-left:9pt;padding-right:9pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May 19, 2024</ix:nonNumeric></span></div><div style="padding-left:9pt;padding-right:9pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">LIFECORE BIOMEDICAL, INC.</ix:nonNumeric></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.694%"><tr><td style="width:1.0%"/><td style="width:36.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.591%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-27446</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">94-3025618</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission file number)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.416%"><tr><td style="width:1.0%"/><td style="width:25.670%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.179%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:49.851%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3515 Lyman Boulevard</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Chaska,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Minnesota</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">55318</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">952</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">368-4300</ix:nonNumeric></span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Not Applicable</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="padding-left:9pt;padding-right:9pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="padding-left:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="padding-left:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"/><td style="width:33.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.754%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">LFCR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="padding-left:9pt;padding-right:9pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company &#160; <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="padding-left:9pt;padding-right:9pt"><span><br/></span></div><div style="padding-left:9pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160; &#9744;</span></div><div style="padding-left:9pt"><span><br/></span></div><div id="ic1b6338d76814ba78e54bc0bef9e66a9_7"></div><div style="text-align:justify"><span><br/></span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 3.02 Unregistered Sales of Equity Securities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As described in Item 5.02 below, on May 20, 2024, Lifecore Biomedical, Inc. (the &#8220;Company&#8221;) issued a restricted stock unit (&#8220;RSU&#8221;) award with respect to 525,000 shares of its common stock and a performance stock unit (&#8220;PSU&#8221;) award for up to 1,500,000 shares of its common stock to Paul Josephs under the Company&#8217;s Equity Inducement Plan adopted on March 20, 2024.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The RSU award and PSU award were granted in reliance upon the exemption from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The securities have not been registered under the Securities Act, and may not be offered or sold without registration or an applicable exemption from registration requirements. The information set forth below in Item 5.02 with respect to the Company&#8217;s grants of these inducement awards to Mr. Josephs are incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Effective May 19, 2024, James G. Hall resigned as a director of the Company and ceased serving as the Company&#8217;s President and Chief Executive Officer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 20, 2024, Paul Josephs began serving as the Company&#8217;s President and Chief Executive Officer and was elected as a director of the Company. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From April 2021 to May 2024, Paul Josephs, age 58, served as the President and Chief Executive Officer of Woodstock Sterile Solutions (&#8220;WSS&#8221;), a full-service contract development and manufacturing organization (&#8220;CDMO&#8221;) specializing in blow fill seal sterile technology. He also served as a member of the Board of Directors of WSS. In his role as President and Chief Executive Officer of WSS, Mr. Josephs was responsible for the overall financial performance and the leadership of WSS, which has approximately 450 employees. He led initiatives to develop and implement long-term strategic and annual operating plans, build the sales and marketing teams, drive revenue and EBITDA growth, and manage costs. From June 2016 to March 2021, Mr. Josephs was the Head of CDMO operations for Mylan and later Viatris Inc. (Nasdaq: VTRS), which was formed through the merger of Mylan and Upjohn Inc., a legacy division of Pfizer, on November 16, 2020. At Viatris, Mr. Josephs was responsible for the financial and operational performance of the CDMO business, including developing and executing sales and marketing tactics to grow revenue, manage pricing and profitability for all service offerings, and establishing the CDMO business within the legacy Mylan sites. From May 2012 to June 2016, Mr. Josephs was the Senior Vice President, Sales, Marketing &amp; Corporate Development for DPT Laboratories, a leading provider of semi-solid and liquid contract development services. In 2016, Mylan acquired DPT&#8217;s non-sterile CDMO business and Mr. Josephs served as a business lead integrating DPT&#8217;s CDMO business into Mylan, adding programs to the CDMO portfolio, and expanding CDMO agreements within Mylan sites in the United States and Europe.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are no other arrangements or understandings between Mr. Josephs and any other persons pursuant to which Mr. Josephs was appointed President and Chief Executive Officer of the Company nor elected as a director of the Company. Mr. Josephs does not have any family relationship with any of the Company&#8217;s directors or executive officers or any persons nominated or chosen by the Company to be a director or executive officer. Other than with respect to the equity awards contemplated by this Current Report on Form 8-K and the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on March 21, 2024 (the &#8220;March 21 Form 8-K&#8221;), Mr. Josephs does not beneficially own any shares of the Company&#8217;s common stock, and Mr. Josephs does not have any direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a) of Regulation S-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with the offer letter agreement dated March 20, 2024 between the Company and Mr. Josephs that was previously disclosed in the March 21 Form 8-K (the &#8220;Offer Letter&#8221;), on May 20, 2024, the Company granted Mr. Josephs a restricted stock unit (&#8220;RSU&#8221;) award with respect to 525,000 shares of its common stock and a performance stock unit (&#8220;PSU&#8221;) award for up to 1,500,000 shares of its common stock. The RSU award and the PSU award were granted under the Company&#8217;s Equity Inducement Plan adopted on March 20, 2024 (the &#8220;Inducement Plan&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The RSU award will vest and be settled as to 25,000 shares of the RSU on May 20, 2024 and as to 100,000 shares of the RSU on each of the first five anniversaries of May 20, 2024 and is governed by a Restricted Stock Unit Award Agreement attached hereto as Exhibit 10.1 and the Inducement Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The PSU award will vest, if at all, based upon the Performance Price achievement within the five year performance period as compared to a range of ten prices from $7.50 per share to $35.00 per share. The Performance Price is the average Fair Market Values (as defined in the Inducement Plan) of one share of the Company&#8217;s common stock over a period of twenty consecutive trading days within the performance period. To the extent the PSU award becomes vested, the Company will issue Mr. Josephs shares of the Company&#8217;s common stock on the vesting date in settlement of the PSU award, with 50% of the shares so issued being restricted from transfer until the one year anniversary of the vesting date. The PSU award is governed by a Performance Stock Unit Award Agreement attached hereto as Exhibit 10.2 and the Inducement Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing descriptions of the Restricted Stock Unit Award Agreement and Performance Stock Unit Award Agreement are not complete and are qualified in their respective entirety by reference to the full text of such agreements, which are filed with this Current Report on Form 8-K as Exhibit 10.1 and Exhibit 10.2 and incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Also on May 20, 2024, in accordance with the Offer Letter, the Company and Mr. Josephs entered into a participation notice with respect to Mr. Joseph&#8217;s participation in the Lifecore Biomedical, Inc. Executive Change in Control Severance Plan (the &#8220;CIC Severance Plan&#8221;). As provided in the participation notice, Mr. Josephs is eligible to receive benefits at the &#8220;Tier 1&#8221; level upon a Qualifying Termination. Further, if Mr. Josephs&#8217; employment is terminated by the Company without Cause (other than a Qualifying Termination), the same severance benefits under the CIC Severance Plan as if he had experienced a Qualifying Termination without duplication in the amount of or types of payments or benefits, provided that (a) the vesting of any PSU award will not be accelerated and (b) Mr. Josephs must satisfy the conditions required by the CIC Severance Plan to receive severance benefits (including execution of a general release of claims that is not revoked or rescinded). Capitalized terms used in this Current Report on Form 8-K and not otherwise defined have the respective meanings ascribed to them in the CIC Severance Plan. The foregoing description of the participation notice is not complete and is qualified in its entirety by reference to the full text of such participation notice, which is filed with this Current Report on Form 8-K as Exhibit 10.3 and incorporated by reference herein.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following exhibits are furnished as part of this report:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.040%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101lifecorersuaward.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101lifecorersuaward.htm">Restricted Stock Unit Award Agreement dated May 20, 2024 to Paul Josephs under Lifecore Biomedical Inc. Equity Inducement Plan.</a></span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102lifecorepsuaward.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit102lifecorepsuaward.htm">Performance Stock Unit Award Agreement dated May 20, 2024 to Paul Josephs under Lifecore Biomedical Inc. Equity Inducement Plan.</a></span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103lifecoreparticip.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit103lifecoreparticip.htm">Participation Notice with Paul Josephs dated May 20, 2024 under the Lifecore Biomedical, Inc. Executive Change in Control Severance Plan.</a></span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ic1b6338d76814ba78e54bc0bef9e66a9_10"></div><div style="text-align:center"><span><br/></span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:29.25pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SIGNATURE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date: May 22, 2024</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"/><td style="width:16.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.674%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.959%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LIFECORE BIOMEDICAL, INC.</span></td></tr><tr style="height:13pt"><td colspan="9" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:13pt"><td colspan="9" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By:</span></div></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John D. Morberg</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John D. Morberg</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101lifecorersuaward.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i63f2bc2b70184690b6891cbad7fb9891_1"></div><div style="min-height:50.4pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.1</font></div></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIFECORE BIOMEDICAL, INC. <br>EQUITY INDUCEMENT PLAN<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RESTRICTED STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Restricted Stock Unit Agreement (the &#8220;Agreement&#8221;) is made and entered into as of May 20, 2024 (the &#8220;Grant Date&#8221;) by and between Lifecore Biomedical, Inc., a Delaware corporation (the &#8220;Company&#8221;), and Paul Josephs (&#8220;you&#8221; or the &#8220;Participant&#8221;) pursuant to the Company&#8217;s  Equity Inducement Plan (as it may be amended from time to time, the &#8220;Plan&#8221;).  To the extent any capitalized terms used in this Agreement are not defined, they shall have the meaning ascribed to them in the Plan, which has been delivered to you and is incorporated into this Agreement by reference.  In the event of a conflict between the terms and provisions of the Plan and the terms and provisions of this Agreement, the Plan terms and provisions shall prevail. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the mutual agreements herein contained and intending to be legally bound hereby, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Pursuant to the Plan, the Company hereby grants to you, and you hereby accept from the Company, 525,000 Stock Units (the &#8220;Restricted Stock Units&#8221;), on the terms and conditions set forth herein and in the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  So long as your Service continues, the Restricted Stock Units shall vest in accordance with the following schedule&#58; (a) 25,000 of the Restricted Stock Units shall vest on the Grant Date and (b) 100,000 of the Restricted Stock Units shall vest on each of the first five anniversaries of the Grant Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of the termination of your Service for any reason, all unvested Restricted Stock Units shall be immediately forfeited without consideration except as provided in the Company&#8217;s Executive Change in Control Severance Plan (the &#8220;CIC Severance Plan&#8221;) and your Participation Notice dated May 20, 2024 under the CIC Severance Plan.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Settlement of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Restricted Stock Units shall be automatically settled in Shares upon vesting pursuant to Section 2 above, provided that the Company shall have no obligation to issue Shares pursuant to this Agreement unless and until you have satisfied any applicable tax withholding obligations pursuant to Section 5 below.  Issuance of such Shares shall be made as soon as reasonably practicable following the applicable vesting date, but in any event no later than March 15 of the year following which the Restricted Stock Units vest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">No 83(b) Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  You expressly acknowledge that because the award of Restricted Stock Units consists of an unfunded promise by the Company to deliver Shares in the future, subject to the terms hereof, it is not possible to make a so-called &#8220;83(b) election&#8221; with respect to the award of Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  You agree to make arrangements satisfactory to the Company for the satisfaction of any applicable withholding tax obligations that arise in connection with the Restricted Stock Units.  The Company shall not be required to issue Shares pursuant to this Agreement unless and until such obligations are satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Tax Advice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  You represent, warrant and acknowledge that the Company has made no warranties or representations to you with respect to the income tax consequences of the transactions contemplated by this Agreement, and you are in no manner relying on the Company or the Company&#8217;s representatives for an assessment of such tax consequences.  YOU UNDERSTAND THAT THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE.  YOU SHOULD CONSULT YOUR OWN TAX ADVISOR REGARDING ANY RESTRICTED STOCK UNITS.  NOTHING STATED HEREIN IS INTENDED OR WRITTEN TO BE USED, AND CANNOT BE USED, FOR THE PURPOSE OF AVOIDING TAXPAYER PENALTIES.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">Non-Transferability of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Except as permitted by applicable law, Restricted Stock Units shall not be anticipated, assigned, attached, garnished, optioned, transferred or made subject to any creditor&#8217;s process, whether voluntarily or involuntarily or by the operation of law.  However, this section shall not preclude you from designating a beneficiary who will receive the Shares underlying any vested Restricted Stock Units in the event of your death, nor shall it preclude a transfer of such Shares by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt;text-decoration:underline">No Employment Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  You understand, acknowledge and agree that nothing in this Agreement shall affect in any manner whatsoever the status of your Service or the right or power of the Company (or any Parent, Subsidiary, or Affiliate) to terminate your Service with the Company (or any Parent, Subsidiary, or Affiliate) at any time, for any such reason, with or without cause, in accordance with applicable law.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Voting and Other Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the terms of this Agreement, you shall not have any voting rights or any other rights and privileges of a stockholder of the Company unless and until you receive Shares upon settlement of vested Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without regard to the conflict of laws principles thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All notices, communications and documents under this Agreement shall be in writing.  All notices, communications, and documents directed to the Company and related to the Agreement, if not delivered by hand, shall be mailed to the Company&#8217;s principal executive office, Attention&#58; Stock Administration.  The current address of the Company&#8217;s principal executive office is&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lifecore Biomedical, Inc. <br>3515 Lyman Blvd. <br>Chaska, MN 55318</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All notices, communications, and documents intended for you and related to this Agreement, if not delivered by hand, shall be mailed to your address shown on the last page of this Agreement or such other address as you may specify by notice complying with this section.  Notices, communications, and documents not delivered by hand shall be mailed by registered or certified mail, return receipt requested, postage prepaid.  All mailings and deliveries related to this Agreement shall be deemed received only when actually received.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the limitations set forth in this Agreement, this Agreement shall be binding upon, and inure to the benefit of, the executors, administrators, heirs, legal representatives, successors, and assigns of the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement may be signed in counterparts with the same effect as if the signature to each such counterpart were upon a single instrument, and all counterparts shall be deemed an original of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If any provision of this Agreement is held to be unenforceable for any reason, it shall be adjusted rather than voided, if possible, in order to achieve the intent of the parties to the extent possible.  In any event, all other provisions of this Agreement shall be deemed valid and enforceable to the full extent possible.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Signature&#59; Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. By executing this Agreement, you agree to be subject to the terms of the Plan and this Agreement. As of the Grant Date, this Agreement and the Plan, as well as the CIC Severance Plan and the related Participation Notice, set forth the entire understanding between you and the Company regarding this Award and supersede all prior oral and written agreements on that subject, including that certain Offer Letter between you and the Company dated March 20, 2024.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt;text-decoration:underline">Securities Law Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">You have been advised that this Award and the underlying Shares have not been registered under the Securities Act, or any state securities laws and, therefore, must be held indefinitely and cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an exemption from such registration requirements is available&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">You are receiving this Award and any Shares to be issued to you hereunder for your own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and you have no present intention of selling, granting any participation in, or otherwise distributing the same&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">You have such knowledge and experience in financial and business matters that you are capable of evaluating the merits and risks of such acquisition, are able to incur a complete loss of such investment without impairing your financial condition and are able to bear the economic risk of such acquisition for an indefinite period of time&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">You understand and acknowledge that any certificates representing any Shares, and all certificates issued in exchange for or in substitution of such certificates, will bear, upon the original issuance of the Shares and until the legend is no longer required under applicable requirements of the Securities Act or applicable state securities laws, a legend with respect to the transfer restrictions described herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">You understand and acknowledge that the Company is not obligated to file and has no present intention of filing with the SEC or with any state securities administrator any registration statement in respect of resales of any Shares underlying this Award&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">You are familiar with the provisions of Rule 144 under the Securities Act as in effect from time to time, that, in substance, permits limited public resale of &#8220;restricted securities&#8221; acquired, directly or indirectly, from the issuer of such securities (or from an affiliate of such issuer), in a non-public offering subject to the satisfaction of certain conditions&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">You further understand that at the time you wish to sell the Shares underlying this Award, there may be no public market upon which to make such a sale, and that, even if such a public market then exists, the Company may not be satisfying the current public information requirements of Rule 144, and that, in such event, you may be precluded from selling such Shares under Rule 144 even if the minimum holding period requirement had been satisfied&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">You acknowledge that you have been afforded the opportunity (i) to ask such questions as you deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of this Award, and (ii) to consult your own tax, legal and financial advisors regarding this Award&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">You acknowledge and agree that in making the decision to accept this Award, you have not relied on any statement, whether written or oral, regarding the subject matter of this Agreement, except as expressly provided in this Agreement and in the attachments and exhibits to this Agreement, including the Plan&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">You acknowledge that the representations and warranties and agreements contained herein are made by you with the intent that they may be relied upon by the Company in determining your eligibility to acquire this Award and the Shares subject to this Award, as applicable. You further agree that by accepting this Award, you will be representing and warranting that the foregoing representations and warranties are true as at the time that the Shares are delivered with the same force and effect as if they had been made by you at the delivery time, and that they will survive the acquisition by you of this Award and the underlying Shares and will continue in full force and effect notwithstanding any subsequent issuance (if applicable) or disposition by you of this Award and the underlying Shares, as applicable.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * * *<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Signature Page Follows)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><div id="i63f2bc2b70184690b6891cbad7fb9891_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement on this 20th day of May, 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIFECORE BIOMEDICAL, INC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Craig Barbarosh&#160;&#160;&#160;&#160;</font></div><div style="padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Craig Barbarosh</font></div><div style="margin-bottom:12pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chair of the Board of Directors</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PARTICIPANT&#58; Paul Josephs</font></div><div style="margin-bottom:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;  Paul Josephs&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Signature)</font></div><div style="margin-bottom:24pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102lifecorepsuaward.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic45556d02c194d8d928b7f6ed5abb695_1"></div><div style="min-height:50.4pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIFECORE BIOMEDICAL, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EQUITY INDUCEMENT PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PERFORMANCE STOCK UNIT AWARD AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Performance Stock Unit Agreement (the &#8220;Agreement&#8221;) is made and entered into as of May 20, 2024 (the &#8220;Grant Date&#8221;) by and between Lifecore Biomedical, Inc., a Delaware corporation (the &#8220;Company&#8221;), and Paul Josephs (&#8220;you&#8221; or the &#8220;Participant&#8221;) pursuant to the Company&#8217;s Equity Inducement Plan (as it may be amended from time to time, the &#8220;Plan&#8221;). To the extent any capitalized terms used in this Agreement are not defined, they shall have the meaning ascribed to them in the Plan, which has been delivered to you and is incorporated into this Agreement by reference. In the event of a conflict between the terms and provisions of the Plan and the terms and provisions of this Agreement, the Plan terms and provisions shall prevail (unless expressly set forth herein or in Exhibit A attached hereto). </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the mutual agreements herein contained and intending to be legally bound hereby, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Performance-Based Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Pursuant to the Plan, the Company hereby grants to you, and you hereby accept from the Company, a maximum number of 1,500,000 performance-based Stock Units (the &#8220;PSUs&#8221;), on the terms and conditions set forth herein and in the Plan. The terms of this Agreement and the PSUs are subject in all respects to your participation in the Company&#8217;s Executive Change in Control Severance Plan (the &#8220;CIC Severance Plan&#8221;) and your Participation Notice dated May 20, 2024 under the Severance Plan. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Vesting of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The PSUs shall vest in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> attached hereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of the termination of your Service for any reason, the PSUs shall be subject to the vesting or forfeiture provisions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> attached hereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Settlement of PSUs&#59; Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon vesting of the PSUs pursuant to Section 3 above, the Company will issue Shares in settlement of such vested PSUs, provided that (a) 50% of such Shares shall be subject to Restrictions during the Restricted Period (as described herein) and upon issuance shall be referred to herein as the &#8220;Restricted Shares&#8221; and (b) the Company shall have no obligation to issue Shares pursuant to this Agreement unless and until you have satisfied any applicable tax withholding obligations pursuant to Section 7 below. Issuance of such Shares and Restricted Shares shall be made as soon as reasonably practicable following the applicable vesting date, but in any event no later than March 15 of the year following which the PSUs vest. Notwithstanding the later delivery to you of Shares or Restricted Shares, you will be deemed to be the record owner of such Shares or Restricted Shares on the vesting date. Restricted Shares shall be issued in restricted book-entry until the Restrictions on the Restricted Shares lapse and the Shares are released to you. The &#8220;Restricted Period&#8221; means the period from the vesting date to the one year anniversary thereof.  During the Restricted Period, the Restricted Shares, and all rights with respect to the Restricted Shares, may not be sold, assigned, transferred, exchanged, pledged, hypothecated or otherwise encumbered or disposed of (such limitations on transferability being herein referred to as &#8220;Restrictions&#8221;), but you will have all other rights of a Lifecore stockholder with respect to the Restricted Shares, including, but not limited to, the right to vote and receive dividends on the Restricted Shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">No 83(b) Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. You expressly acknowledge that because the award of PSUs consists of an unfunded promise by the Company to deliver Shares in the future, subject to the terms hereof, it is not possible to make a so-called &#8220;83(b) election&#8221; with respect to the award of PSUs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. You agree to make arrangements satisfactory to the Company for the satisfaction of any applicable withholding tax obligations that arise in connection with the PSUs (including settlement to Shares or Restricted Shares). The Company shall not be required to issue Shares pursuant to this Agreement unless and until such obligations are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Tax Advice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. You represent, warrant and acknowledge that the Company has made no warranties or representations to you with respect to the income tax consequences of the transactions contemplated by this Agreement, and you are in no manner relying on the Company or the Company&#8217;s representatives for an assessment of such tax consequences. YOU UNDERSTAND THAT THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE. YOU SHOULD CONSULT YOUR OWN TAX ADVISOR REGARDING ANY PSUs. NOTHING STATED HEREIN IS INTENDED OR WRITTEN TO BE USED, AND CANNOT BE USED, FOR THE PURPOSE OF AVOIDING TAXPAYER PENALTIES.</font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Non-Transferability of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as permitted by applicable law, PSUs shall not be anticipated, assigned, attached, garnished, optioned, transferred or made subject to any creditor&#8217;s process, whether voluntarily or involuntarily or by the operation of law. However, this section shall not preclude you from designating a beneficiary who will receive the Shares or Restricted Shares underlying any vested PSUs in the event of your death, nor shall it preclude a transfer of such Shares or Restricted Shares by will or by the laws of descent and distribution.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. You understand, acknowledge and agree that (i) the PSUs, the Shares subject to the PSUs and Performance Prices are subject to adjustment upon the occurrence of one or more of the events described in Section 10.1 of the Plan, in accordance with the terms and conditions set forth in the Plan and (ii) the Performance Prices may be adjusted, as determined by the Committee in its sole discretion, in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the PSUs, including upon any event described in Section 10.1 and&#47;or 10.2 of the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary in this Agreement, no amounts shall be paid to you under this Agreement during the six-month period following your &#8220;separation from service&#8221; to the extent that the Committee determines that you are a &#8220;specified employee&#8221; (each within the meaning of Section 409A of the Code) at the time of such separation from service and that paying such amounts at the time or times indicated in this Agreement would be a prohibited distribution under Code Section 409A(a)(2)(b)(i). If the payment of any such amounts is delayed as a result of the previous sentence, then on the first business day following the end of such six-month period (or such earlier date upon which such amount can be paid under Section 409A of the Code without being subject to such additional taxes), the Company shall pay to you in a lump-sum all amounts that would have otherwise been payable to you during such six-month period under this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">No Employment Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. You understand, acknowledge and agree that nothing in this Agreement shall affect in any manner whatsoever the status of your Service or the right or power of the Company (or any Parent, Subsidiary, or Affiliate) to terminate your Service with the Company (or any Parent, Subsidiary, or Affiliate) at any time, for any such reason, with or without cause, in accordance with applicable law.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Voting and Other Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms of this Agreement, you shall not have any voting rights or any other rights and privileges of a stockholder of the Company unless and until you receive Shares upon settlement of vested PSUs.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without regard to the conflict of laws principles thereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All notices, communications and documents under this Agreement shall be in writing. All notices, communications, and documents directed to the Company and related to the Agreement, if not delivered by hand, shall be mailed to the Company&#8217;s principal executive office, Attention&#58; Stock Administration. The current address of the Company&#8217;s principal executive office is&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lifecore Biomedical, Inc.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3515 Lyman Blvd. <br>Chaska, MN 55318</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All notices, communications, and documents intended for you and related to this Agreement, if not delivered by hand, shall be mailed to your address shown on the last page of this Agreement or such other address as you may specify by notice complying with this section. Notices, communications, and documents not delivered by hand shall be mailed by registered or certified mail, return receipt requested, postage prepaid. All mailings and deliveries related to this Agreement shall be deemed received only when actually received.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the limitations set forth in this Agreement, this Agreement shall be binding upon, and inure to the benefit of, the executors, administrators, heirs, legal representatives, successors, and assigns of the parties hereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement may be signed in counterparts with the same effect as if the signature to each such counterpart were upon a single instrument, and all counterparts shall be deemed an original of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If any provision of this Agreement is held to be unenforceable for any reason, it shall be adjusted rather than voided, if possible, in order to achieve the intent of the parties to the extent possible. In any event, all other provisions of this Agreement shall be deemed valid and enforceable to the full extent possible.</font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;                        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.2</font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Signature&#59; Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. By executing this Agreement, you agree to be subject to the terms of the Plan and this Agreement. As of the Grant Date, this Agreement and the Plan, as well as the CIC Severance Plan and the related Participation Notice, set forth the entire understanding between you and the Company regarding this Award and supersede all prior oral and written agreements on that subject, including that certain Offer Letter between you and the Company dated March 20, 2024.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt;text-decoration:underline">Securities Law Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">You have been advised that this Award and the underlying Shares have not been registered under the Securities Act, or any state securities laws and, therefore, must be held indefinitely and cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an exemption from such registration requirements is available&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">You are receiving this Award and any Shares to be issued to you hereunder for your own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and you have no present intention of selling, granting any participation in, or otherwise distributing the same&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">You have such knowledge and experience in financial and business matters that you are capable of evaluating the merits and risks of such acquisition, are able to incur a complete loss of such investment without impairing your financial condition and are able to bear the economic risk of such acquisition for an indefinite period of time&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">You understand and acknowledge that any certificates representing any Shares, and all certificates issued in exchange for or in substitution of such certificates, will bear, upon the original issuance of the Shares and until the legend is no longer required under applicable requirements of the Securities Act or applicable state securities laws, a legend with respect to the transfer restrictions described herein&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">You understand and acknowledge that the Company is not obligated to file and has no present intention of filing with the SEC or with any state securities administrator any registration statement in respect of resales of any Shares underlying this Award&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">You are familiar with the provisions of Rule 144 under the Securities Act as in effect from time to time, that, in substance, permits limited public resale of &#8220;restricted securities&#8221; acquired, directly or indirectly, from the issuer of such securities (or from an affiliate of such issuer), in a non-public offering subject to the satisfaction of certain conditions&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">You further understand that at the time you wish to sell the Shares underlying this Award, there may be no public market upon which to make such a sale, and that, even if such a public market then exists, the Company may not be satisfying the current public information requirements of Rule 144, and that, in such event, you may be precluded from selling such Shares under Rule 144 even if the minimum holding period requirement had been satisfied&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">You acknowledge that you have been afforded the opportunity (i) to ask such questions as you deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of this Award, and (ii) to consult your own tax, legal and financial advisors regarding this Award&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">You acknowledge and agree that in making the decision to accept this Award, you have not relied on any statement, whether written or oral, regarding the subject matter of this Agreement, except as expressly provided in this Agreement and in the attachments and exhibits to this Agreement, including the Plan&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">You acknowledge that the representations and warranties and agreements contained herein are made by you with the intent that they may be relied upon by the Company in determining your eligibility to acquire this Award and the Shares subject to this Award, as applicable. You further agree that by accepting this Award, you will be representing and warranting that the foregoing representations and warranties are true as at the time that the Shares are delivered with the same force and effect as if they had been made by you at the delivery time, and that they will survive the acquisition by you of this Award and the underlying Shares and will continue in full force and effect notwithstanding any subsequent issuance (if applicable) or disposition by you of this Award and the underlying Shares, as applicable.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * * *</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page Follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;                        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><div id="ic45556d02c194d8d928b7f6ed5abb695_4"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement on this 20th day of May, 2024.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIFECORE BIOMEDICAL, INC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Craig Barbarosh&#160;&#160;&#160;&#160;</font></div><div style="padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Craig Barbarosh</font></div><div style="margin-bottom:12pt;padding-left:63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chair of the Board of Directors</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PARTICIPANT&#58; Paul Josephs</font></div><div style="margin-bottom:12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;  Paul Josephs&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Signature)</font></div><div style="margin-bottom:24pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><div id="ic45556d02c194d8d928b7f6ed5abb695_7"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period from the Grant Date to the fifth (5th) anniversary of the Grant Date. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the average Fair Market Values of one Share over a period of twenty (20) consecutive trading days within the Performance Period.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Vesting of PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">General Achievement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to this Exhibit A, the number of PSUs that shall vest (if any) during the Performance Period shall be based on achievement of the Performance Price and determined by multiplying the number of PSUs by the Performance Vesting Percentage, as determined in accordance with the following table&#58;</font></div><div style="padding-left:90pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:54.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Price</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Vesting Percentage</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#60;$7.50</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.50</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12.50</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17.50</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.50</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30.00</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.00</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 37pt;text-align:center;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vesting date for any PSUs that become so vested shall be the last trading day of the relevant Performance Price measurement period.  In no event will the Performance Vesting Percentage exceed 100% regardless of the Performance Price and in no event shall the PSUs be vested with respect to any Performance Price on more than one occasion. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Forfeiture of Unvested PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent not vested by the last day of the Performance Period, the PSUs shall be forfeited to the Company without payment of any consideration therefor as of the last day of the Performance Period and your rights under this Agreement will terminate effective as of such date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If your Service terminates during the Performance Period (other than a Qualifying Termination as described in the CIC Severance Plan), all vested and unvested PSUs will be forfeited to the Company without payment of any consideration therefor as of the date of such termination and your rights under this Agreement will terminate effective as of such date. For the avoidance of doubt, if your Service is terminated without Cause (other than a Qualifying Termination), the vesting of the PSUs will not be accelerated.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Effect of Change in Control&#59; Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon a Change in Control (as defined in the Plan) or in the event that you experience a Qualifying Termination, in either case within the Performance Period, the PSUs shall vest based on a Performance Vesting Percentage that assumes that the Performance Price is equal to the per Share consideration received by holders of Shares in the Change in Control (as determined by the Committee), which shall be the &#8220;target&#8221; level of performance as described in the Plan and the CIC Severance Plan.  To the extent that such per Share consideration is between the two Performance Vesting Percentages, the PSU vesting will be prorated based on straight line calculation between the Performance Vesting Percentages. Any PSUs that do not become fully vested in accordance with this paragraph shall automatically be cancelled and forfeited as of the date of the Change in Control without payment of any consideration therefor, and the Participant shall have no further right to or interest in such PSUs.</font></div><div style="height:50.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A-1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>exhibit103lifecoreparticip.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i09ea614449c04739875571f4400d0946_1"></div><div style="min-height:50.4pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10.3</font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:96px;margin-bottom:5pt;vertical-align:text-bottom;width:228px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PARTICIPATION NOTICE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIFECORE BIOMEDICAL, INC.<br>EXECUTIVE CHANGE IN CONTROL SEVERANCE PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 20, 2024</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Paul&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 20, 2024, you and Lifecore Biomedical, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) entered into an offer letter (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Offer Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) relating to your employment as the Company&#8217;s President and Chief Executive Officer.  This Participation Notice supersedes the terms of the Offer Letter with respect to your participation in the Lifecore Biomedical, Inc. Executive Change in Control Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), a copy of which has been provided to you.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is providing you with this Participation Notice to inform you that you have been designated as a Tier 1 Participant in, and are eligible to receive Severance Benefits under, the Plan.  Capitalized terms used but not otherwise defined in this Participation Notice will have the definitions provided in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Tier 1 Participant in the Plan, you will be eligible to receive the Severance Benefits upon a Qualifying Termination.  Subject to your timely execution and, to the extent applicable, non-revocation of a Release in accordance with the terms of the Plan, and subject to the additional requirements specified in the Plan and this Participation Notice, the Company will pay or provide to you the Severance Benefits available to a Tier 1 Participant described in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to these benefits, if your employment is terminated by the Company without Cause (other than a Qualifying Termination), you will be entitled to the same Severance Benefits under the Plan as if you had experienced a Qualifying Termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (a) the vesting of any performance stock units or performance-based equity awards will not be accelerated and (b) you must satisfy the conditions required by the Plan to receive Severance Benefits (including that you execute a general release of claims as provided in the Plan and you do not revoke or rescind such release). In no event will you receive or be entitled to any duplication in the amount of or types of payments or benefits to you in the event of termination of employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Participation Notice is subject in all respects to the terms, conditions and provisions of the Plan, as amended from time to time, all of which are made a part of and incorporated by reference into this Participation Notice, including without limitation the covenants detailed in Section 12 of the Plan.  In the event of any conflict between the terms of this Participation Notice and the terms of the Plan, the terms of the Plan shall govern.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By signing below, you acknowledge and agree that (i) you have received and reviewed a copy of the Plan, (ii) participation in the Plan requires that you irrevocably and voluntarily agree to the terms of the Plan and the terms set forth in this Participation Notice, and (iii) any prior agreement, arrangement and understanding between you and the Company and&#47;or any subsidiary with respect to severance or change in control benefits is hereby superseded, revoked and ineffective (including, but not limited to, your Offer Letter).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you have any questions regarding the foregoing, please contact the Chair of the Board of Directors of the Company.  Please confirm your agreement to the foregoing by executing this Participation Notice where indicated below and returning a copy to the undersigned.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                               Sincerely,</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                                 LIFECORE BIOMEDICAL, INC.</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                 By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;  Craig Barbarosh&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                Craig Barbarosh</font></div><div style="padding-left:252pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                Chair of the Board of Directors</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACKNOWLEDGED AND AGREED&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;  Paul Josephs&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Paul Josephs</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 20, 2024</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lndc-20240519.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:cfacfc41-a0b5-4de1-8079-b8c458288541,g:a394aa73-034b-4302-b53c-b8c0aae0a0c1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lndc="http://landec.com/20240519" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://landec.com/20240519">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lndc-20240519_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lndc-20240519_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://landec.com/role/DocumentandEntityInformationDocument">
        <link:definition>0000001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>lndc-20240519_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:cfacfc41-a0b5-4de1-8079-b8c458288541,g:a394aa73-034b-4302-b53c-b8c0aae0a0c1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_ac61682f-edea-4f7c-8f6d-941f8caa078c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_df0a376f-01f9-44fe-a5b3-920578cc9ccc_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ab7709f3-ff38-4013-82b9-579302a1c054_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f924c46d-5f0f-47ee-a8c8-67478ca8e02c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1bb34645-1d9b-4740-bca5-fd7aed622662_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5f6f59ab-44f2-401c-b2ca-685eaaf7f731_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8190ee84-132f-4ae9-abed-d9bf0e2980a3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_b2fed81c-7b7e-4f13-9491-c473114b1e5e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2c440d82-4b68-4223-a62b-9ecdc4d42274_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6765329a-72d4-44b5-bfed-1f9c2ffef6da_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_77ebb3b4-de45-4bfb-86a5-8d41de15ea1d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_44944663-2fa9-4bc7-bc24-7fd2f8ad3b25_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_442e7bf6-a9bd-4f71-8e48-09029877a3bd_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_40e34199-3e3a-4f49-a919-ca2d355f079f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7a92bb53-d4d8-4374-99a8-93a3e3636be9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_4143d8fa-2ed8-4bb4-a1ea-1bd633f25649_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_eaefbcaf-2b75-4740-81ec-7667650e14aa_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a1083793-6070-49ac-a98f-2df7b906fa7b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_4f39e288-049b-4589-b2a5-dfd4a4fb8b9e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8cb1cb5e-4b7c-46f7-a244-130179b579a5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ae3544cd-388e-4eed-b39d-68c0b2d8e4b4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c8ed2ac3-d01b-4252-977d-a7a2fe8ac23b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_16991a55-8168-4a82-b704-7c50433445ff_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>lndc-20240519_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:cfacfc41-a0b5-4de1-8079-b8c458288541,g:a394aa73-034b-4302-b53c-b8c0aae0a0c1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://landec.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="lndc-20240519.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://landec.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6dc32d8e-32a4-4fd4-af96-7ddf3337ed6f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_DocumentType_6dc32d8e-32a4-4fd4-af96-7ddf3337ed6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_864ce098-a1a9-4139-b447-982c5a917df8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_DocumentPeriodEndDate_864ce098-a1a9-4139-b447-982c5a917df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8416eb14-2329-4c6c-aaf2-588441c45592" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityRegistrantName_8416eb14-2329-4c6c-aaf2-588441c45592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9f727903-d5da-4b31-9b3b-d10b6fdf3ea8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityCentralIndexKey_9f727903-d5da-4b31-9b3b-d10b6fdf3ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a6377533-4def-4975-b976-9302229832c1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a6377533-4def-4975-b976-9302229832c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0cad6dab-2c36-4e16-9dde-22237d0d437b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityFileNumber_0cad6dab-2c36-4e16-9dde-22237d0d437b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_df90581e-b0dc-41b8-a764-cbd6f5e517f0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityTaxIdentificationNumber_df90581e-b0dc-41b8-a764-cbd6f5e517f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_647ee52f-9320-4866-8fa3-31c5ebf3d382" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityAddressAddressLine1_647ee52f-9320-4866-8fa3-31c5ebf3d382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c09dfc09-73fc-4dd6-b027-b08c5bb80953" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityAddressCityOrTown_c09dfc09-73fc-4dd6-b027-b08c5bb80953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_69a2f95a-1377-4b6f-a25b-76b1c2db8ca6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityAddressStateOrProvince_69a2f95a-1377-4b6f-a25b-76b1c2db8ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8c3e5fd5-b6b8-4974-bf3a-bf2e3266ff5e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityAddressPostalZipCode_8c3e5fd5-b6b8-4974-bf3a-bf2e3266ff5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2eb44454-5539-4402-82a9-83d4c4d9ca6f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_CityAreaCode_2eb44454-5539-4402-82a9-83d4c4d9ca6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4383a255-368c-4047-bdf1-15582fe42552" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_LocalPhoneNumber_4383a255-368c-4047-bdf1-15582fe42552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_0729bdbf-7f11-45a5-b051-90b07ba2fdd8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_WrittenCommunications_0729bdbf-7f11-45a5-b051-90b07ba2fdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_99eda0db-891e-4578-9375-05f0f8051d0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_SolicitingMaterial_99eda0db-891e-4578-9375-05f0f8051d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_09845e3e-46ae-46f5-8674-b62f50dd831a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_PreCommencementTenderOffer_09845e3e-46ae-46f5-8674-b62f50dd831a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6a78117f-9b57-4ca5-b025-267faa9164d6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6a78117f-9b57-4ca5-b025-267faa9164d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5041f9e6-def7-47d6-9dbe-c0667e086dc5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_Security12bTitle_5041f9e6-def7-47d6-9dbe-c0667e086dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9b18d992-061f-4776-88dd-7721d5580fa9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_TradingSymbol_9b18d992-061f-4776-88dd-7721d5580fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ff54a224-e588-4fa9-9b50-9c0302b6b9ad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_SecurityExchangeName_ff54a224-e588-4fa9-9b50-9c0302b6b9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_acd03c6f-5548-4925-89b5-bf3e7c4f4bbe" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_EntityEmergingGrowthCompany_acd03c6f-5548-4925-89b5-bf3e7c4f4bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b6b8d8f0-3fe2-4d1b-898e-6f8281308781" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cea3e56-5465-43f6-95c2-44d497dc9d4b" xlink:to="loc_dei_AmendmentFlag_b6b8d8f0-3fe2-4d1b-898e-6f8281308781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" 'T!*$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@!CS;)!'L)R.H[4>:.RT2Y) 'YTT_(=@7F
MAM15V/2P[SODW>6?I227*1J&8')_A[TPRE,C>21V)JC)K6E_VBEF]X@N&4XC
MW<XJ8N<W:,1:7U9IB:,IO#C%*I##<#Q5<-Y<C1&W CV@AO4U/%_JQA<<=*:=
MT&HZBBBF 4$X&:*&Z'Z4 ,$P*[MN*42@C(%1C+Y4C ]:C,\<@*1/]WKBE*7*
MMA)2Y7IL3K*&!(7I33<@9S&W%4;77M,GNVL(;Y6F4?,F:L3RON$)/)[^M%W%
M^^K7(ISA734)?\ L)*'. II]0Q B8#/\-3535BHMM:A1112*"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!CR[&V[2>*%GW=$/XTR
M9)#)E&QQ40F>)Q&P))]>U#:BM1)2DV^Q8,RCM33=*&VA2?<5G7OB31;&]33K
MJ^5)I 2$)ZU=5HE4,&R&Z&A\T%><78BE5I59M1:=OP)_-7.*=595*.69N*L*
M<J"*6^JV*@Y-:JPM(S;3C%+4<IPZ_O,>WK5)7*U'>8O>D$RL2!T'>HG&9-_F
MD#'2D< $$OLQ^M9IMR:N&O8G\U<9'-()EQDC'-5OM-NH)$Z#G^^*1KV$CB6-
MO^V@IJ-2_P#PPE=]BSYXWE=IX[T&X7/RJ3]*A2XB?(:=.>@#"I$(CY11CUS2
ME-PU:T'9O9DBN&8KW IU1HRF4\#=CFI*L+-;A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOHSZ7AY9A5J-U6[(]TM-N<+D@#J:L4R$*/NT^OR"+O%'V=VWJ%%%%, HHHH
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MA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !L\0PV>E6CI") 9Y,%1@'YN>_&:_27X&_ _PM\&?"\&BZ1:J)=F))M@#/\
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M!X"O[.43]$?^"LFOWVB?LQWIMI2AN(9D?'IM%?@M;YNGV/,"S=?:OJ#X]_\
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M]-1T_&B+[Y^M Z?C1%]\_6OYYELOD?I?<DHHHIC"BBB@".;K^-?FI_P<9_\
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MQ^E?N_\ LF?M(>&/VD_A79>,]!NE>18$2[7>"5D(R1QTK^<41R0PHT<7F?\
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M$8&LG%Z;']/>C:S:Z[:1:GI]Q'+;2)F.5.0X]0?2KTG]*^1O^"0W[2Z_'O\
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M/P_HNAVOV31[!(8P/NH*^&S;Q)A0KRIX2FII;M]SZ#"<,>THJ525C^?74/\
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MUC^A^6TI*C5371G],/AFX^V^%=,N_P#GK8PM^: U^4__  7X^,/V_P 7^'O
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MB.,J8_*!4_>'K12.'*D1]>U.+<7= FHKR/0OV>OC_P"+O@OXFAN=+N&N++S
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M!Q[UX:5C5@[.-H^\">36]X3^%OQ(^)-L]UX%\#ZIJ"1OM9K6U9Q^@K]AQU'
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M:\\=?] &R_[Z/^%-*:?NNP2X XF?2/\ X$CZR^&?Q4\1?"3Q!;>(_#MPZ#S
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M,H/U%#PMMQMQ^%3G/84URW5N!4M):@TY:,J^6^&4J<$8S7\_/_!2[PU?Z/\
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MJJIM2\MC^@3]AG]N?P#^U+X"M)8]1CBUJ*%4O())1N>0\D@ <5]"P"4Q%)9
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MBZ@?JP_PK\Z_XA?-K_>$?4RXJO*ZA^1_19_PNOX4_P#0]Z=_W_H_X77\*?\
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M<G='[,U4BO;*:XEAAN%9T;YU!Y!K\(_&W_!7/]J[Q1 Z:/\ $'4M+D.<>1<
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M?BKP+J$6M^%=8FTRYB;=#- >0P^M?1GPI_X*R_M0?#E%MM9\=ZCJL:$#9/<
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MD;1IV.> +=B/Y4ZU\)Z[J4GVA=%U!F[1PV[G] *_H%?_ ()F_L@N,'X9Q_\
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M%-PP6PT"\?(X$=LY_D*Z#PA\"OC!XQO4M-(^'VJ%I& >1]-EQCZ[:_?;0?\
M@GQ^RSX;D672?AU$C+T)<'^E>B^%_A!X"\'0B#0?#UM"JC _=*?Z5P8GQ/7L
MW&A2?JV=%+A-\R]I-6/&O^":7P>N/A3^RKX4TO5[>6"^33U%S%(""#GN#7T+
M&)F),A7&>.:2"R\@&--HC_A11C%2"#*[7;.#Q7Y-BL34Q>(G6GO)GUV'HQP]
M%4ELB2BCI16!N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT4FY3_$*"RC +#GI0 M%&0>AH) ZD4!=!12!E(W \>M*"#T- !1110 4444
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M1A5*JN!7PQ^PA_P52\3?M8_$N#P-J7A^SMQ)NRT"D'@#V]Z^Y5< >5DYQFO
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MQW.R6@ZBBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB*LKA05C/R)P6^](>BT4Y'AV&VD  D^][T[+F7?H.3"<&-5 PRY&645]2?\
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MW1<%B.]=<O0<]J_GCB7B?$9_B'RMJFMD?UYP-P-@>%<"F[2K/XI=O)#&MHF
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M01RM;P@-QA&('Z5^A_\ P6^_;"7PGX7M_@GX5U;+ZM:F2=XWY4JQ&/UK\O\
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MD>KZ9#JEK.KQ3(&4CW%?S7:W:_\ "'?&:YTVV_=2Z5XF95([".;_ .M7[_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU; E["&CFTE'5P,@9QWKZ3_X('_$;2-1T36O!2W,8FLK%"ZLP&<N.GK78?\
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M,M<\;?8?B=\.O#TES=O<.]ZEO'EF4*<9_$U]7A<XI8/BW$X+$R_=ST^9Y=;
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139747345366432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>May 19, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 19,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIFECORE BIOMEDICAL, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001005286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-27446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3025618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3515 Lyman Boulevard<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chaska,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">368-4300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFCR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MP(.V6%&D(S%$!   AA   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R5
MF&UO\C84AO^*E4G3)K7-"X'2#I!H2C?T](65;H^T:1],8L!J8F>V4\J_WW&
MA.T))^Q+B9.<.U?..;X==["1ZEVO&3/D,TN%'CIK8_);U]7QFF547\F<";BR
ME"JC!H9JY>I<,9J405GJ!I[7<S/*A3,:E.=F:C20A4FY8#-%=)%E5&WO6"HW
M0\=W#B=>^6IM[ EW-,CIBLV9^2V?*1BYE4K",R8TEX(HMAPZ8__V+@AM0'G'
M[YQM]-$QL:^RD/+=#J;)T/$L$4M9;*P$A9\/%K$TM4K \?=>U*F>:0./CP_J
M#^7+P\LLJ&:13+_RQ*R'3M\A"5O2(C6O<O,+V[]0U^K%,M7E7[+9W1N&#HD+
M;62V#P:"C(O=+_W<)^(H(.B=" CV 4')O7M027E/#1T-E-P09>\&-7M0OFH9
M#7!<V*K,C8*K'.+,Z%[&!239$"H2,A&&FRV9BEVU;=8.UP>N@:?9&#?>*]_M
ME(,3RD]T2_R;"Q)X0?CO:!<8*]"@ @U*N<X)N4A^,$7^'"^T45#*OYJ =@IA
MLX+M[UN=TY@-'6A@S=0'<T;??^?WO)\0OD[%U\'4ZT2^;7/6!(>']R^_(!!A
M!1&>!S%CBDM;T(1 6S3RX$J'ZK65KUN1=5&]?6N]LA6W!03$9YHU<N$ZC].'
M2?3R.B%WTY>GR?TT&C]>D.ES=(4P]BK&WCF,$210T12F0<(^R1>V;:+$E3S/
M\SVO&_1["-9UA75]#M94Q%+E4I7S\H+,#=252$4B60 O8,ND,9^X^/T$(>Q7
MA/US"!]XRLASD2V8:@+!-2!EE\%U&&(9NZEX;L[A>:.?9)I -?F2QSL[.TV'
M*]Z$EQTOZ/;\/H+G>[7I>N< CI,$C$A?' [((]Q'7D1C'5LD.UV_2QZW&17D
M3A8I^Z JP5B/%@C_?[%&=@1]]R8WHI$3EXO65+_3"PRM7A)\U-&_0:OFQ$S)
M#R[BYCSBFD_/&%J]&OBXG_\7;2:U 4_Y@^<G)VJ+8K?;P;NO7B1\W-O+"H[A
M&^XT"BYPTPTPD'I-\%O,7,:0D]E:"LPW6D0ZO?YEV/$\C*A> 7S<N+\J;@P3
MD)@L*\3>-70C%2ZTI*EF&%+M_C[NT'.9\I@;+E;D"=I;<9HV\N JK3RUU_NX
M4<\4NXPA/0SFU^Z#A\%"J<C+<GFB?KA>*UGM^CYNTM^03;4N@*P5$)=M PQJ
MVP]PCW[C!E9(N21^\,/B1S)G<0']UOA]T:)D^Q.6L[F1\3N&5KM\@-ORFZ*)
M;;'Y-EO(Q@9K$7A\B%XQDJ/O?-R #UDAD\]X3<6*G?Q2;!%Z'L_OQ[]B3+6;
M!V>Y^21C:F6S]#,HF+5UB9R*YOKA@JT]59MY@'OQ&#H]*;O](:6K1A1<X"2*
M>[2KM#OT)VI?7I.4+4'(N[H&7U:[3>]N8&1>;C07TL"VM3Q<,PI3S]X UY=2
MFL/ [EVK?SV,_@%02P,$%     @ P(.V6)^@&_"Q @  X@P   T   !X;"]S
M='EL97,N>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES
M^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'
MKEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H
M4JPKH\^6E :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\
M"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GE
MW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6K
MC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B7X2]
M_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+
M-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,
M7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GU
MX1W;^PO\*KY?7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)
M>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SC
MMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L
M#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX
M'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<1
M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ P(.V6)>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
MP(.V6"0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ P(.V6 =!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " # @[98$W3)
M(.T    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " # @[98F5R<(Q &  "<)P  $P              @ '+ 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,"#MEA1I",Q1 0  (80
M   8              " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " # @[98GZ ;\+$"  #B#   #0              @ &&#
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ,"#MEB7BKL<P    !,"   +
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4!08     "0 ) #X"  #F$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lndc-20240519.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://landec.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="lndc-20240519.htm">lndc-20240519.htm</File>
    <File>lndc-20240519.xsd</File>
    <File>lndc-20240519_lab.xml</File>
    <File>lndc-20240519_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lndc-20240519.htm": {
   "nsprefix": "lndc",
   "nsuri": "http://landec.com/20240519",
   "dts": {
    "inline": {
     "local": [
      "lndc-20240519.htm"
     ]
    },
    "schema": {
     "local": [
      "lndc-20240519.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "lndc-20240519_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lndc-20240519_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://landec.com/role/DocumentandEntityInformationDocument",
     "longName": "0000001 - Document - Document and Entity Information Document",
     "shortName": "Document and Entity Information Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lndc-20240519.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lndc-20240519.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://landec.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001005286-24-000071-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001005286-24-000071-xbrl.zip
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ME5>,D1(N"TPJH@:3Y:D9.BM=9GR)!^F]EYSP#O(MWK,S3= #2#<WU5VMJQ7
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M9?*[2]?!=A4?!/J(D]0TAI)VB23U]I#DJ_V3UTTDN5*B!]()9*DC@4#YG%%
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M 9SZF1F* DZ41H._6[7IX4,W[Z:XYOD <7!0F%+T9*H+()Q_P$@ ]V$. H^
M#R_"J50'B&!*3"$BU0<4B&B2B<@',H[%0(X4#3Q4,D%Q*?->IKLX)$TXY/$4
M;:,EQ@/=&\!'.6P#CBA2L1[1D</; $<",LRM$W<L#ANFE@1'G:D^? E8MPG0
MXKV-\!$@C8133?JQ[A4>&? Y;Q*G2#,STCD<.>&86QX]NOO%<!&MZL/&#QA
M::9&4L=BK4QBE>=P /";/(\!@*H00#D%P ,V F "[($_.]\&NHL$)&11R-X
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M!3)L^,$7J#I6FJE;S"6H3 LN<&0?'WH+P8S5:4R*.N=9K2(N+E$"\ -4&2Q
M6C /;3-7Q(6T "N&PS)!"X?#YNC<M-TH\F:+LLH^!/T_T\A0[QRS-35HI($_
M%K[<U[-2S@GCD*A]%#!TW;<%Q:[\MXMA6U2^@K13'<\,&_C&"=O!G%"^W,R
MHH*V4KL@?Q FYNR_/K)5=NT(="$TY6@;G,# [K8"C1-,3YJ2!@^8"^RXNZM+
M:PCU:F=A9#6W%/XQ+&)9-K.[O[TO/DU@'/$^'D6; EMT' ]D_E6VQ.<SL;^_
MN_WZ$1M;T#8>063>G8DZMRN3KU%775]Z%'F1<>!((!^8L7<TQ#)'U\JM:J@=
M=5X$5K?<YS*GY:%CF/U"$YR:=XE[3#D.9"5?%8O:M,6<]T*B<5LSNZ+N +=
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MN4>50]%5/3-4<(#NVE>?(N&O3 M2M%R*1*9B-<+$Q-E<B:&2>6D[_7#ZUZ;
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MJV[7ZYM7%M?LO<83U0/7;1=+FY^BBK<)J[I_J"^7],\P9WJ%A]OU,1IO3+R
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M?:Y*_66T3[H!RX[(9DWWL5I5\#!6((4WR_T0)2R,*#2?D4,IT6!2Z%[5_.6
M=K74Z *#>.J,1/X&GC+YA>(D/]GD9_ BD&AAJ:A)@."(;X"9,G\G=4B!]SQ&
MT6*%U5RKTNUH)95?X("^(FKHTQES!DH^.ZUA8&N3S<'W4L!^OJC?"TIMP$:X
MI"> H7IWDW--[D/@:P;X,0KRPZGD 0+<55)4(6 1^*!"P#]J-,L*_AIB"*/U
MP T _5T(7]LJ?2Q? G721X]"I4E3,^CW?C]5>C ?&29!8"ET@TK&$ ":Z6 A
M7H,.F4[2.0$&R1!>@+[#.F@)-,+_UFHG';=S='J>V5?J3B. _=^JSAHT BJD
M(0=VCABXDI%97<R\<0A8& '^?V:$!I'(;9V2"</S&"FI?!1H3Q2%+^RYW[?!
MTB(8\Y$"!J7KTJ?N7"ZH-*175), ,8[J&$U$G%M<,XG2:.X.YZU-G 5;!>JZ
MV&C,I]G@.I6 'KJJ3;_E6%D6S$B]X8#GKT[(@T^!NP^4?03VA/(;E;(U:%#C
MJZM^%4(" 1XQ0'!"E&4 %H*G+> P3&!A E9&E9L^!:,3B&J0\$"O+U)>C48H
M1D>Q4<SH!!KY$D$C\2JX1&^H^[%W=71HHA*I=1,BA7HB0@-$T?4O2<B E-U=
M3=;:JJVZRU#%^7\&^"A-!K22KA-I$Z%\.E,F,LP28.T=^0W@( &GVM$XHY%/
M_VJ3WZXN^^]2J.*PZH@$[DZ*9*1O5<=XBD;O?,Q/TS_%.%2#(=4'(.6\&0@C
M79>/;2^&P-)2N3]G@&U%>.ZNDI&.30[C=$'KT4LN; *S9UM=H)M4!B(X!DD$
MDD.=\LA.'QG\*TD,PYA#A1B 685(X$_N*;I!G*6X+*=8 P'DI2,!)0YY3 <\
M0#\%%TT5;VHQH"Q7:!IIK(/_!J8I5Y?!+J]7F98\-/2OP*K!'O&8I52BY9U;
MQ<5E%+.:1OHLY +1[^4$7UD[Y&43U<>%_$ G4S28C/$)YME<9.&&CBZNR D=
MX$LA.?:EBC^S QF^II&(3;@%!CK7CDO P<;V5TM" Y](R1NS TUAGC+,?9PT
M4Y*A"*U4T!4AAO/DMYX7>5DC7*LZGS(RW)P?NS@>M!)Z)66B V:X0^@WB3);
M'SO@,:$A[%08O-Z",E2MU5LZDLP8FP:E.3P2@^%/(* P/()'I_5&NHD$\G[I
MMN@5NB[*H0F%N>J&%LQOJ1T_%?E$U@!#*;Y!U[#@$"DI/#,# *='BP5*6G M
MTCW5?@$ =FW-E3=^0UC=>D96?F)?L$CYJLK5Q7$T9(D.7<+*48]E<>'B4!DE
M^GE':/'4LWZ*O5-8A&("DC'6;K$WAJ4H=S&_&X 2>,_Y3:P8V";G)FL%M++*
MN64Z!&,<5Y7;  6J9E;S@6;I)%(BI,V]J"#XLQ-BJ4*_IPE>\N,OKCW[LD<N
M-J"8) U^YVX)FD>!7&V)%\(4Z:MLPKG1MA*) Q8R@ QH',"@N D5U.?!K%6H
MRP>WRDM":9D\-$(0'9B94']G9?)(O1CH0SFAD(CI!NJE,0X\E2>B- UAGIMP
MAF\PGMX_:R(LRO&N.W630KADHT23)>E;O[YT<=,+53I%^LH,R*A&*5Z0_#$:
M0)D\)KXBVV+(,),_BUYP'H? ';$2,%-,Y^ASC3Z/O$#APHCT)4HKT*$J2"4G
M:DES$ER*$>=7D0;["I+QU82!=>"M&.U43MKJB.?3!8D+:%GHE84Q7SA?%$%[
M@P[C-4H5!/( X[-Q'!B_6) E@HA-[P7JU'2ANKA+Z,WU465@Z>%=#JH>_E6B
M+^3XL2>*5J3R*A;'!ETR0@<QU J!@K#*:%W51"FSB1RJ31UF;$UC,-G')FP*
MBZ-8XC#F VCJ.K:;4=8"KN\N:'CQD9*K(A^EZ%<'WT&2@6X#;U8%^;+DP46.
MVR\D.@T 4PY&NX)7SC=1N,3+OPL"PN3"::33[D8;@;32I8! #"!BT7."3:J
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M5.H\J2HE8K&.'>+#OQ* 2'JO/4S-96K.H<3!*T&!K&>%9&'JO&%0FJB/D6&
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M&Q\N[N9[;[F]8'-C3'M_ %!+ P04    " # @[98AY;\U1T*  !]50  %0
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M7[;H3!_5+;JS:CXO<&&,+N/=EPY'WF/X1-T]8"^S>P?()<HN5?"<!1V!,RM
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MP/'!PT1WZ=ZO/S[X'U!+ 0(4 Q0    ( ,"#ME@@IKTPM10  '-R   >
M          "  0    !E>&AI8FET,3 Q;&EF96-O<F5R<W5A=V%R9"YH=&U0
M2P$"% ,4    " # @[98'%I+>;L=  "PPP  '@              @ 'Q%
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M-3$Y+GAS9%!+ 0(4 Q0    ( ,"#MEB'EOS5'0H  'U5   5
M  "  6U7  !L;F1C+3(P,C0P-3$Y7VQA8BYX;6Q02P$"% ,4    " # @[98
M.FCO$+0&   O,0  %0              @ &]80  ;&YD8RTR,#(T,#4Q.5]P
<<F4N>&UL4$L%!@     '  < Z $  *1H      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>lndc-20240519_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lndc-20240519.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001005286</identifier>
        </entity>
        <period>
            <startDate>2024-05-19</startDate>
            <endDate>2024-05-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001005286</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-05-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">LIFECORE BIOMEDICAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-27446</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">94-3025618</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3515 Lyman Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Chaska,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">55318</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">368-4300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">LFCR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
